Latest Articles

Healio (5/29) reported that on May 28, the FDA “announced the approval of Tauvid [flortaucipir F18], an IV injection that is used to help image a specific characteristic of Alzheimer’s disease in the brain known as tau pathology.” The agency has approved Tauvid for “adults who have cognitive impairment and are being evaluated for Alzheimer’s disease, according to an FDA press release.” Tauvid “is a radioactive diagnostic agent that is indicated for positron emission tomography imaging of the brain” that is “used to assess the density and distribution of aggregated tau neurofibrillary tangles…which is a primary signal of Alzheimer’s disease, the release said.”

Read More

Did You Know…

It is estimated that 20% of people age 55 years or older experience some type of mental health concern. The most common conditions include anxiety, severe cognitive impairment, and mood disorders (such as depression or bipolar disorder).

– American Association of Geriatric Psychiatry (2008)